HCA Healthcare, Inc. (NYSE:HCA) Shares Sold by D.A. Davidson & CO.

D.A. Davidson & CO. lowered its holdings in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 20.7% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 4,400 shares of the company’s stock after selling 1,151 shares during the quarter. D.A. Davidson & CO.’s holdings in HCA Healthcare were worth $1,191,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in HCA. Norges Bank acquired a new stake in HCA Healthcare during the fourth quarter valued at $694,985,000. Northern Trust Corp grew its position in HCA Healthcare by 3.2% during the third quarter. Northern Trust Corp now owns 2,152,419 shares of the company’s stock valued at $529,452,000 after buying an additional 67,332 shares during the period. Morgan Stanley grew its position in HCA Healthcare by 1.4% during the third quarter. Morgan Stanley now owns 2,150,009 shares of the company’s stock valued at $528,860,000 after buying an additional 30,072 shares during the period. Invesco Ltd. lifted its holdings in HCA Healthcare by 5.0% during the third quarter. Invesco Ltd. now owns 2,146,844 shares of the company’s stock valued at $528,081,000 after purchasing an additional 102,025 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in HCA Healthcare by 0.6% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,126,550 shares of the company’s stock valued at $304,935,000 after purchasing an additional 6,407 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,600 shares of the business’s stock in a transaction on Monday, May 6th. The shares were sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, SVP Kathryn A. Torres sold 973 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $312.00, for a total transaction of $303,576.00. Following the transaction, the senior vice president now directly owns 22,365 shares of the company’s stock, valued at approximately $6,977,880. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of the company’s stock in a transaction on Monday, May 6th. The stock was sold at an average price of $309.00, for a total transaction of $494,400.00. Following the transaction, the executive vice president now directly owns 34,124 shares in the company, valued at $10,544,316. The disclosure for this sale can be found here. Insiders sold a total of 13,617 shares of company stock worth $4,321,986 in the last 90 days. 1.70% of the stock is owned by insiders.

HCA Healthcare Stock Up 1.1 %

Shares of NYSE:HCA opened at $318.70 on Monday. The company has a market capitalization of $83.47 billion, a PE ratio of 15.89, a P/E/G ratio of 1.48 and a beta of 1.66. The company has a current ratio of 1.16, a quick ratio of 1.02 and a debt-to-equity ratio of 29.26. HCA Healthcare, Inc. has a twelve month low of $215.96 and a twelve month high of $335.83. The firm has a 50 day simple moving average of $318.89 and a 200-day simple moving average of $305.81.

HCA Healthcare (NYSE:HCAGet Free Report) last issued its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, topping the consensus estimate of $5.01 by $0.35. HCA Healthcare had a net margin of 8.20% and a return on equity of 674.49%. The business had revenue of $17.34 billion during the quarter, compared to the consensus estimate of $16.81 billion. During the same quarter in the previous year, the firm earned $4.93 EPS. The company’s revenue was up 11.2% compared to the same quarter last year. On average, equities analysts predict that HCA Healthcare, Inc. will post 20.84 EPS for the current fiscal year.

HCA Healthcare declared that its board has authorized a share buyback program on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in outstanding shares. This buyback authorization authorizes the company to purchase up to 7.4% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s leadership believes its stock is undervalued.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be given a $0.66 dividend. The ex-dividend date of this dividend is Friday, June 14th. This represents a $2.64 annualized dividend and a yield of 0.83%. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

Analyst Upgrades and Downgrades

Several research firms have issued reports on HCA. StockNews.com raised shares of HCA Healthcare from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 18th. Deutsche Bank Aktiengesellschaft raised their price objective on shares of HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a research report on Friday, April 12th. Royal Bank of Canada lifted their price target on shares of HCA Healthcare from $322.00 to $329.00 and gave the company an “outperform” rating in a research report on Monday, April 29th. Oppenheimer lifted their price target on shares of HCA Healthcare from $330.00 to $345.00 and gave the company an “outperform” rating in a research report on Monday, April 29th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $335.00 price objective on shares of HCA Healthcare in a report on Wednesday, April 10th. Four research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $317.00.

Read Our Latest Stock Report on HCA

HCA Healthcare Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Featured Articles

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.